These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 32071060)

  • 1. Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients.
    Colque CA; Albarracín Orio AG; Feliziani S; Marvig RL; Tobares AR; Johansen HK; Molin S; Smania AM
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071060
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic Analysis Identifies Novel Pseudomonas aeruginosa Resistance Genes under Selection during Inhaled Aztreonam Therapy
    McLean K; Lee D; Holmes EA; Penewit K; Waalkes A; Ren M; Lee SA; Gasper J; Manoil C; Salipante SJ
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Evolution of the Pseudomonas-Derived Cephalosporinase (PDC) Structure and Activity in a Cystic Fibrosis Patient Treated with β-Lactams.
    Colque CA; Albarracín Orio AG; Tomatis PE; Dotta G; Moreno DM; Hedemann LG; Hickman RA; Sommer LM; Feliziani S; Moyano AJ; Bonomo RA; K Johansen H; Molin S; Vila AJ; Smania AM
    mBio; 2022 Oct; 13(5):e0166322. PubMed ID: 36073814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study.
    Courtois N; Caspar Y; Maurin M
    Int J Antimicrob Agents; 2018 Sep; 52(3):358-364. PubMed ID: 29775685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penicillin-binding protein 3 is a common adaptive target among Pseudomonas aeruginosa isolates from adult cystic fibrosis patients treated with β-lactams.
    Clark ST; Sinha U; Zhang Y; Wang PW; Donaldson SL; Coburn B; Waters VJ; Yau YCW; Tullis DE; Guttman DS; Hwang DM
    Int J Antimicrob Agents; 2019 May; 53(5):620-628. PubMed ID: 30664925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections.
    Feliziani S; Luján AM; Moyano AJ; Sola C; Bocco JL; Montanaro P; Canigia LF; Argaraña CE; Smania AM
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
    Rees VE; Deveson Lucas DS; López-Causapé C; Huang Y; Kotsimbos T; Bulitta JB; Rees MC; Barugahare A; Peleg AY; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.
    Greipel L; Fischer S; Klockgether J; Dorda M; Mielke S; Wiehlmann L; Cramer N; Tümmler B
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6726-6734. PubMed ID: 27572404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.
    Martin LW; Robson CL; Watts AM; Gray AR; Wainwright CE; Bell SC; Ramsay KA; Kidd TJ; Reid DW; Brockway B; Lamont IL
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
    Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Drug Resistance Determinants in a Clinical Isolate of Pseudomonas aeruginosa by High-Density Transposon Mutagenesis.
    Sonnabend MS; Klein K; Beier S; Angelov A; Kluj R; Mayer C; Groß C; Hofmeister K; Beuttner A; Willmann M; Peter S; Oberhettinger P; Schmidt A; Autenrieth IB; Schütz M; Bohn E
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in
    Jorth P; McLean K; Ratjen A; Secor PR; Bautista GE; Ravishankar S; Rezayat A; Garudathri J; Harrison JJ; Harwood RA; Penewit K; Waalkes A; Singh PK; Salipante SJ
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe.
    Mustafa MH; Chalhoub H; Denis O; Deplano A; Vergison A; Rodriguez-Villalobos H; Tunney MM; Elborn JS; Kahl BC; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6735-6741. PubMed ID: 27572406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone.
    López-Causapé C; Sommer LM; Cabot G; Rubio R; Ocampo-Sosa AA; Johansen HK; Figuerola J; Cantón R; Kidd TJ; Molin S; Oliver A
    Sci Rep; 2017 Jul; 7(1):5555. PubMed ID: 28717172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.
    Sherrard LJ; Tai AS; Wee BA; Ramsay KA; Kidd TJ; Ben Zakour NL; Whiley DM; Beatson SA; Bell SC
    PLoS One; 2017; 12(3):e0172179. PubMed ID: 28273168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, β-lactam resistance, and peptidoglycan structure.
    Ropy A; Cabot G; Sánchez-Diener I; Aguilera C; Moya B; Ayala JA; Oliver A
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3925-34. PubMed ID: 25896695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-level resistance and clonal diversity of Pseudomonas aeruginosa among chronically colonized cystic fibrosis patients.
    Ferreira AG; Leão RS; Carvalho-Assef AP; da Silva ÉA; Firmida Mde C; Folescu TW; Paixão VA; Santana MA; de Abreu e Silva FA; Barth AL; Marques EA
    APMIS; 2015 Dec; 123(12):1061-8. PubMed ID: 26522829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.